
	May 15, 2008

Now Available:
Download the podcast of Dr. Peterfy's presentation

With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.

MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.

MSK Video Report:

Charles Peterfy, MD, PhD presents "MRI as an Entry and Outcome Measure for RA Clinical Trials" at the ISEMIR Conference

Arthritis: 8-Year Data Confirm Etanercept Safety, Efficacy in Juvenile Rheumatoid Arthritis
Long-term open-label data show that etanercept (Enbrel) is safe and effective over 8 years of continuous treatment of children with JRA...

Arthritis: Breastfeeding May Slash Mother's RA Risk
Women who breastfeed for ≥ 13 months have a 50% reduced risk of developing RA...

Consumer News: Outside Workers Least Likely to Get Skin Exams
Workers who are overexposed to the sun are not getting regular exams to detect early warning signs of skin cancer...

New from PubMed: Chronic Widespread Musculoskeletal Pain: A Comparison of Those Who Meet Criteria for Fibromyalgia and Those Who Do Not
Fibromyalgia patients reported more severe symptoms and consequences on their daily life than patients suffering from chronic pain without widespread allodynia...

BioPharm Business: Roche's Fifth Phase III Study for Actemra Inhibits Joint Damage and Improves Physical Function of Patients With RA
Roche's Actemra (tocilizumab), a humanized interleukin-6 receptor-inhibiting monoclonal antibody, can significantly inhibit structural damage to joints in patients with RA...